A new approach to modelling interactions between treatment and continuous covariates in clinical trials by using fractional polynomials

被引:196
作者
Royston, P
Sauerbrei, W
机构
[1] MRC, Canc Trials Div, Clin Trials Unit, London NW1 2DA, England
[2] Univ Hosp Freiburg, Inst Med Biometry & Med Informat, D-79104 Freiburg, Germany
关键词
covariate transformation; interactions; subgroup analysis; clinical trials; continuous covariates; effect modification;
D O I
10.1002/sim.1815
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We consider modelling interaction between a categoric covariate T and a continuous covariate Z in a regression model. Here T represents the two treatment arms in a parallel-group clinical trial and Z is a prognostic factor which may influence response to treatment (known as a predictive factor). Generalization to more than two treatments is straightforward. The usual approach to analysis is to categorize Z into groups according to cutpoint(s) and to analyse the interaction in a model with main effects and multiplicative terms. The cutpoint approach raises several well-known and difficult issues for the analyst. We propose an alternative approach based on fractional polynomial (FP) modelling of Z in all patients and at each level of T. Other prognostic variables can also be incorporated by first constructing a multivariable adjustment model which may contain binary covariates and FP transformations of continuous covariates other than Z. The main step involves FP modelling of Z and testing equality of regression coefficients between treatment groups in an interaction model adjusted for other covariates. Extensive experience suggests that a two-term fractional polynomial (FP2) function may describe the effect of a prognostic factor on a survival outcome quite well. In a controlled trial, this FP2 function describes the prognostic effect averaged over the treatment groups. We refit this function in each treatment group to see if there are substantial differences between groups. Allowing different parameter values for the chosen FP2 function is flexible enough to detect such differences. Within the same algorithm we can also deal with the conceptually different cases of a predefined hypothesis of interaction or searching for interactions. We demonstrate the ability of the approach to detect and display treatment/covariate interactions in two examples from controlled trials in cancer. Copyright (C) 2004 John Wiley Sons, Ltd.
引用
收藏
页码:2509 / 2525
页数:17
相关论文
共 26 条
[1]   DANGERS OF USING OPTIMAL CUTPOINTS IN THE EVALUATION OF PROGNOSTIC FACTORS [J].
ALTMAN, DG ;
LAUSEN, B ;
SAUERBREI, W ;
SCHUMACHER, M .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (11) :829-835
[2]   Fractional polynomial model selection procedures: Investigation of type I error rate [J].
Ambler, G ;
Royston, P .
JOURNAL OF STATISTICAL COMPUTATION AND SIMULATION, 2001, 69 (01) :89-108
[3]  
Andrews DF, 1985, DATA
[4]  
Armitage P., 2002, STAT METHODS MED RES
[5]   Subgroup analysis and other (mis)uses of baseline data in clinical trials [J].
Assmann, SF ;
Pocock, SJ ;
Enos, LE ;
Kasten, LE .
LANCET, 2000, 355 (9209) :1064-1069
[6]   Dynamic Cox modelling based on fractional polynomials:: time-variations in gastric cancer prognosis [J].
Berger, U ;
Schäfer, J ;
Ulm, K .
STATISTICS IN MEDICINE, 2003, 22 (07) :1163-1180
[7]  
Bonetti M, 2000, STAT MED, V19, P2595, DOI 10.1002/1097-0258(20001015)19:19<2595::AID-SIM562>3.0.CO
[8]  
2-M
[9]  
BYAR DP, 1980, B CANCER, V67, P477
[10]  
Clarke M, 1998, LANCET, V351, P1451